Author

Michael Lim

Stanford University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Alfredo Quinones-Hinojosa· 1 shared Anupama Kumar· 1 shared Carlos A. Pardo· 1 shared Cynthia L. Sears· 1 shared Fausto J. Rodriguez· 1 shared Florian Breitwieser· 1 shared Gary L. Gallia· 1 shared George R Nageeb· 1 shared

Activity by Year

2016-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Alfredo Quinones-Hinojosa

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Glioblastoma model mouse rescue from mortality by brain-targeted catalytically-enhanced angiotensin-converting enzyme 2 mutant-antibody fusion protein

Pete Heinzelman, George R Nageeb, John Choi, Justin Liu, Si Yeon Lee, Philip A Romero, Michael Lim

The paper shows that combining ACE2dm-s1 with a STING agonist improves survival in GBM model mice, unlike losartan alone, and suggests ACE2dm-s1 modulates the tumor microenvironment.

bioRxiv · Nov 4, 2026 · PreprintCancer Biology

Next-generation sequencing in neuropathological diagnosis of infections of the nervous system

Steven L. Salzberg, Florian Breitwieser, Anupama Kumar, Haiping Hao, Peter Burger, Fausto J. Rodriguez, Michael Lim, Alfredo Quinones-Hinojosa, Gary L. Gallia, Jeffrey A. Tornheim, Michael T. Melia, Cynthia L. Sears, Carlos A. Pardo

This study evaluates the feasibility of next-generation sequencing for diagnosing CNS infections using brain and spinal cord biopsies, showing successful pathogen identification in three patients.

bioRxiv · Feb 9, 2016Genomics